Fujita A, Inoue Y, Sasaki H, Nakajima S, Sekine K, Honda R, Asakawa M, Suzuki A
Division of Respiratory Diseases, Minamiichijo Hospital, Sapporo, Japan.
Gan To Kagaku Ryoho. 1991 Oct;18(13):2283-7.
Thirty-one patients with inoperable squamous cell carcinoma of the lung were treated with a combination of cis-platin (CDDP, 100 mg/m2 day 1), ifosfamide (IFX, 2 g/m2 day 1, 2, 3; with mesna) and vindesine (VDS, 3 mg/m2 day 1). The overall response rate (PR) was 71.0% with 22 partial responses. The median duration of response was 180 days. The median duration to show 50% decrease was 29 days. Myelosuppression and renal toxicity were severe. We concluded that the CIV regimen against squamous cell carcinoma of the lung was more effective yet more toxic than the other regimen containing CDDP and that candidates for this therapy must be carefully chosen.